Montelukast Prescribing at PONTELAND MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,002
Total Quantity
26.1K
NHS Cost
£1.3K
vs National Avg
+46.3%
PONTELAND MEDICAL GROUP prescribed 1,002 items of Montelukast over the last 12 months at a cost of £1,265 to the NHS. This is 46.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
86
Jul 2026
77
Jul 2026
92
Jul 2026
91
Jul 2026
80
Jul 2026
75
Jul 2026
88
Jul 2026
89
Jul 2026
82
Jul 2026
69
Jul 2026
87
Jul 2026
86
Prescribing Details
| Total Items | 1,002 |
|---|---|
| Total Quantity | 26,119 |
| Total NHS Cost | £1,265 |
| Presentations | 3 different forms |
| vs National Average | +46.3% |
Montelukast Prescribing Comparison
| This practice | 1,002 items |
|---|---|
| National average per practice | 685 items |
| Difference | +46.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.